The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
- 17 February 2011
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 117 (7), 2102-2112
- https://doi.org/10.1182/blood-2010-08-263111
Abstract
P2Y12, the Gi-coupled platelet receptor for adenosine diphosphate (ADP), plays a central role in platelet function. Patients with congenital P2Y12 defects display a mild to moderate bleeding diathesis, characterized by mucocutaneous bleedings and excessive post-surgical and post-traumatic blood loss. Defects of P2Y12 should be suspected when ADP, even at high concentrations (≥ 10μM), is unable to induce full, irreversible platelet aggregation. Tests that evaluate the degree of inhibition of adenylyl cyclase by ADP should be used to confirm the diagnosis. Drugs that inhibit P2Y12 are potent antithrombotic drugs, attesting the central role played by P2Y12 in platelet thrombus formation. Clopidogrel, the most widely used drug that inhibits P2Y12, is effective both in monotherapy and in combination with acetylsalicylic acid. The most important drawback of clopidogrel is its inability to inhibit adequately P2Y12-dependent platelet function in approximately one-third of patients who are therefore not protected from major cardiovascular events. New drugs, such as prasugrel and ticagrelor, which effectively inhibit P2Y12 in the majority of patients, proved to be more efficacious than clopdidogrel in preventing major cardiovascular events. Although they increase the incidence of major bleedings, the net clinical benefit is in favor of the new P2Y12 inhibitors.Keywords
This publication has 88 references indexed in Scilit:
- The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid raftsProceedings of the National Academy of Sciences of the United States of America, 2006
- Platelet Aggregation and Adenosine Diphosphate/Adenosine Triphosphate Receptors: A Historical PerspectiveSeminars in Thrombosis and Hemostasis, 2005
- The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptorTrends in Pharmacological Sciences, 2005
- N‐linked glycosylation of platelet P2Y12 ADP receptor is essential for signal transduction but not for ligand binding or cell surface expressionFEBS Letters, 2004
- Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270Blood, 2003
- Identification and Biological Activity of the Active Metabolite of ClopidogrelThrombosis and Haemostasis, 2000
- A Key Role of Adenosine Diphosphate in the Irreversible Platelet Aggregation Induced by the PAR1-Activating Peptide Through the Late Activation of Phosphoinositide 3-KinaseBlood, 1999
- ADP Receptors and Clinical Bleeding DisordersArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregationProceedings of the National Academy of Sciences of the United States of America, 1998
- Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregatesBlood, 1990